Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson. - Wikidata - wikimedia - TriplyDB

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

http://www.wikidata.org/entity/Q37137953

about

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis.Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis.Medication use and kidney cancer survival: A population-based study.Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model.Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis.Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin Statins and metformin for chemoprevention of hepatocellular carcinoma

P2860

Q33648824-D807AFD4-0F25-4173-B650-7914AAFF596E Q33919105-46E0EAC0-CA2E-4667-91F1-475BC569156E Q37706025-13D5C9D1-34DC-4C18-8431-944859B942B5 Q38723341-245E0F8C-47D5-4888-8230-678FF7581BD7 Q39204274-4742EB38-18AB-4E29-8842-F9CEE0601C05 Q39238333-CC4353D5-0161-42EC-B600-6D365260D287 Q41548205-6F89B946-E470-4116-9420-7B8A0DED81D4 Q42244223-99A037AA-6DD8-43DC-B09B-DFD74E21CAAF Q47333254-781888FB-884B-4F80-B6F7-C4EE178FB72D Q50053806-A0BDF72E-6D34-45B8-B780-8086D917ABA8 Q52590946-389D5DEC-FABD-4E16-883F-4DDD31403C5B Q53272010-87581954-EC71-408D-B4F9-E78619A61E13 Q57176118-4BFD51A5-8579-4D08-90F0-E871B294477C Q59150549-9F03C056-9897-43E2-8476-5134A30D930C

P2860

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

http://www.wikidata.org/entity/Q37137953

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

@en

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

@nl

type

label

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

@en

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

@nl

prefLabel

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

@en

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

@nl

P1433

Q37137953-A0C4733F-944C-423F-8105-669879DEDBAE

P1476

Q37137953-03972AB4-8E9B-4457-9D3B-1A674D1AFC4A

P2093

Q37137953-326BB640-071B-435D-BC68-391C09A32574

Q37137953-36F4B615-507F-4381-BB56-AEEE79F52944

Q37137953-371E039B-87E3-49C0-8E0E-FE0872904735

Q37137953-862E0169-61C0-419D-9DD8-F46E0F467568

Q37137953-C2C243E2-5D8B-4104-BA1F-35ADC9AC30E9

Q37137953-D7949D86-4663-40C4-8BBE-142C3C726EBC

P2860

Q37137953-01657B31-342C-4F02-A28F-AD16CB5FF728

Q37137953-176E33FC-0A00-4991-A60C-71ADD32A6728

Q37137953-211E2228-119D-4B6A-B80D-739BBD84F391

Q37137953-23D472C6-E65E-4281-9990-5210FF4A6A92

Q37137953-275F9A80-91FF-4DA4-88E5-48253B56066F

Q37137953-400E6F5C-0D92-469B-80FA-2336992EED6E

Q37137953-4EB87226-45BD-444D-9C64-8035B33637E1

Q37137953-503826E4-AE31-4832-B180-B55FA0DD474D

Q37137953-7126AF05-4FA4-477C-BD58-1C731FF79613

Q37137953-7F49DAF9-16F6-48C8-AD63-748376DF6608

P304

Q37137953-F023CDCE-6267-4FC5-8ACA-A7068B47DB3C

P31

Q37137953-0EAF8969-F296-4B07-845B-071806532F9E

P356

Q37137953-6C57D71B-7F89-427B-90FF-CBE514A275CF

P407

Q37137953-A259481B-94D0-463E-AE38-3EF40F55049F

P433

Q37137953-5130C9E9-F341-4023-9552-F0C2B9F4E233

P478

Q37137953-802340AB-E0F8-4D6D-B358-CBF248F537DD

P50

Q37137953-19BA9F49-EAFD-491F-A403-10104D16D390

Q37137953-79E77F0E-CBF4-47CB-8501-BBA03DCFF451

Q37137953-AEBC7DFE-C835-4237-80A6-253425416F7A

P577

Q37137953-86770FCB-9AF8-440E-A0C0-B88AA271499B

P698

Q37137953-B919C8AA-E1C1-498B-8EA1-F83FB05EBD20

P921

Q37137953-8D843654-C43D-497C-AD28-B95A277E03E7

P932

Q37137953-19918E1D-78B7-4075-B19E-C317AB6807B0

P356

JCO.2015.63.3511

P1433

Journal of Clinical Oncology

P1476

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

@en

P2093

Ann L Oberg

http://www.w3.org/2001/XMLSchema#string

Emma R Leof

http://www.w3.org/2001/XMLSchema#string

Gloria M Petersen

http://www.w3.org/2001/XMLSchema#string

Kari G Chaffee

http://www.w3.org/2001/XMLSchema#string

Patrick A Burch

http://www.w3.org/2001/XMLSchema#string

Roongruedee Chaiteerakij

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin and the risk of cancer: time-related biases in observational studies

Time-dependent bias was common in survival analyses published in leading clinical journals.

Time-dependent covariates in the Cox proportional-hazards regression model.

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.

Standards of medical care in diabetes--2011.

Metformin use is associated with better survival of diabetic patients with pancreatic cancer

Immortal time bias in pharmaco-epidemiology.

The secret of immortal time bias in epidemiologic studies.

The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.

Metformin in cancer treatment and prevention.

P304

1898-1904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2015.63.3511

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Lewis R. Roberts

P577

2016-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27069086

http://www.w3.org/2001/XMLSchema#string

P921

P932

4966342

http://www.w3.org/2001/XMLSchema#string